DUBLIN, Feb. 19, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/9sjkz9/asiapacific) has announced the addition of the "Asia-Pacific In-Vitro Fertilization Services Market - Opportunities and Forecasts, 2015 - 2020" report to their offering.
The Asia-Pacific IVF services market was evaluated at $1.9 billion in 2014 and is estimated to garner $3.5 billion by 2020, registering a CAGR of 10.8% during the forecast period 20152020.
This market is expected to witness significant growth during the forecast period on account of the delayed pregnancies, rising infertility rates due to dysfunctional lifestyles, environmental pollution, increasing disposable incomes and emergence of newer fertility tourism destinations.
In addition, several academic institutions are collaborating with fertility hospitals and clinics to conduct extensive research & development activities, and provide more effective and better treatment facilities. The other factors, namely technological advancements, utilization of intra-cytoplasmic sperm injection (ICSI) technique and growing popularity of donor egg IVF methods would collectively boost the success rates of IVF cycles.
However, factors such as high costs associated with the treatment, lack of favorable IVF reimbursement policies and lower health awareness, especially in the underdeveloped Asia-Pacific countries, such as Nepal and Myanmar, are the major factors hampering the market growth. In addition, ethical concerns regarding the parental rights are expected to have a restraining effect on the growth of the market.
In terms of revenue, Japan dominates the Asia-Pacific IVF market, owing to the large consumer base, rapid adoption of advanced technologies and availability of skilled workforce. However, the Indian IVF market is anticipated to register a promising CAGR of 14.7% during the forecast period. This is mainly supplemented by factors, such as the rising trend of fertility tourism, favorable regulation of surrogacy and donor services, and wide availability of IVF clinics.
Based on number of cycles performed, Japan is the leading country, accounting for a major share of the market and is expected to maintain this trend throughout the forecast period. However, the India IVF market, in terms of number of cycles performed, is anticipated to grow at a promising CAGR of 16.3% during the study period.
Companies Mentioned:
- Aster Fertility Clinic
- Bloom Fertility Center
- Bourn Hall Clinic
- CRM-MIA-PhilippinesBangkok Fertility Center
- Cadila Healthcare Ltd. (Zydus Cadila group)
- Centre for Reproductive Medicine
- City Fertility
- CloudnineFertility Associates
- Concept Fertility Center
- EMD Serono, Inc.Cook Medical, Inc.
- Fertility Centre, Siloam Hospitals SurabanaVictory Art Lab
- Fertility Plus
- Flinders FertilityEMD Serono, Inc.
- IVF Namba Clinic
- IVF Van Hanh
- IVFAS
- Iwaki Womens Clinic
- (25+ More)
Key Topics Covered:
CHAPTER 1 - Introduction
CHAPTER 2 - Executive Summary
CHAPTER 3 - Asia Pacific IVF Embryo Transfer Market
CHAPTER 4 - China Embryo Transfer Market
CHAPTER 5 - India Embryo Transfer Market
CHAPTER 6 - Korea Embryo Transfer Market
CHAPTER 7 - New Zealand Embryo Transfer Market
CHAPTER 8 - Australia Embryo Transfer Market
CHAPTER 9 - Japan Embryo Transfer Market
CHAPTER 10 - South-East Asia Embryo Transfer Market
For more information visit http://www.researchandmarkets.com/research/9sjkz9/asiapacific
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
